Drugs / TAT4 Gel
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02607670 | Jan → Aug 2016 | — | Topokine Therapeutics, Inc. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TAT4 Gel | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02607670 ↗ |
| Route | Topical | “The participant will apply TAT4 Gel to the nasolabial fold area once daily.” NCT02607670 ↗ |